These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 33124475)

  • 1. Considering Emotion in COVID-19 Vaccine Communication: Addressing Vaccine Hesitancy and Fostering Vaccine Confidence.
    Chou WS; Budenz A
    Health Commun; 2020 Dec; 35(14):1718-1722. PubMed ID: 33124475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.
    Bellanti JA
    Allergy Asthma Proc; 2021 Sep; 42(5):386-394. PubMed ID: 34372964
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines?
    Cooper S; van Rooyen H; Wiysonge CS
    Expert Rev Vaccines; 2021 Aug; 20(8):921-933. PubMed ID: 34252336
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical experimentation and the roots of COVID-19 vaccine hesitancy among Indigenous Peoples in Canada.
    Mosby I; Swidrovich J
    CMAJ; 2021 Mar; 193(11):E381-E383. PubMed ID: 33627413
    [No Abstract]   [Full Text] [Related]  

  • 5. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context.
    Afolabi AA; Ilesanmi OS
    Pan Afr Med J; 2021; 38():3. PubMed ID: 33520072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    Muhajarine N; Adeyinka DA; McCutcheon J; Green KL; Fahlman M; Kallio N
    PLoS One; 2021; 16(11):e0259513. PubMed ID: 34767603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population.
    Edwards B; Biddle N; Gray M; Sollis K
    PLoS One; 2021; 16(3):e0248892. PubMed ID: 33760836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Messages that increase COVID-19 vaccine acceptance: Evidence from online experiments in six Latin American countries.
    Argote Tironi P; Barham E; Zuckerman Daly S; Gerez JE; Marshall J; Pocasangre O
    PLoS One; 2021; 16(10):e0259059. PubMed ID: 34710168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Let's get back to normal": emotions mediate the effects of persuasive messages on willingness to vaccinate for COVID-19.
    Muis KR; Kendeou P; Kohatsu M; Wang S
    Front Public Health; 2024; 12():1377973. PubMed ID: 38756873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Communication Strategies for Mitigating COVID-19 Vaccine-Specific Hesitancy in Canada.
    Merkley E; Loewen PJ
    JAMA Netw Open; 2021 Sep; 4(9):e2126635. PubMed ID: 34591105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment.
    Khubchandani J; Sharma S; Price JH; Wiblishauser MJ; Sharma M; Webb FJ
    J Community Health; 2021 Apr; 46(2):270-277. PubMed ID: 33389421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PANDEMIC framework for encouraging COVID-19 vaccinations.
    Stevens J
    Am J Manag Care; 2021 May; 27(5):e137-e140. PubMed ID: 33733721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social media and vaccine hesitancy.
    Wilson SL; Wiysonge C
    BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33097547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Vaccination Attitudes and Intention: Message Framing and the Moderating Role of Perceived Vaccine Benefits.
    Borah P; Hwang J; Hsu YCL
    J Health Commun; 2021 Aug; 26(8):523-533. PubMed ID: 34424140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from frontline skilled nursing facility staff regarding COVID-19 vaccine hesitancy.
    Berry SD; Johnson KS; Myles L; Herndon L; Montoya A; Fashaw S; Gifford D
    J Am Geriatr Soc; 2021 May; 69(5):1140-1146. PubMed ID: 33764497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring confidence in vaccines in the COVID-19 era.
    Verger P; Dubé E
    Expert Rev Vaccines; 2020 Nov; 19(11):991-993. PubMed ID: 32940574
    [No Abstract]   [Full Text] [Related]  

  • 17. High but slightly declining COVID-19 vaccine acceptance and reasons for vaccine acceptance, Finland April to December 2020.
    Hammer CC; Cristea V; Dub T; Sivelä J
    Epidemiol Infect; 2021 May; 149():e123. PubMed ID: 33972001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the elephant in the room: COVID-19 vaccine hesitancy in Black and Asian communities.
    Darko J
    Br J Gen Pract; 2021 Apr; 71(705):170. PubMed ID: 33771793
    [No Abstract]   [Full Text] [Related]  

  • 19. How can a global pandemic affect vaccine hesitancy?
    Dubé E; MacDonald NE
    Expert Rev Vaccines; 2020 Oct; 19(10):899-901. PubMed ID: 32945213
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and the rise of anti-science.
    Hotez P
    Expert Rev Vaccines; 2021 Mar; 20(3):227-229. PubMed ID: 33599568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 44.